Breast Cancer

In a first, immunotherapy cures late-stage breast cancer

After all else failed, researches trained patient's immune cells to identify and fight cancerous cells.

Blood test may help predict which breast cancers will recur

A research study shows patients with advanced breast cancer tied to an inherited gene mutation treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened.

Novartis breast cancer drug wins European panel backing

Novartis considers its Kisqali to be among a dozen new medicines with blockbuster potential.